Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015699
Filing Date
2024-05-09
Accepted
2024-05-09 16:31:22
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arch20240331_10q.htm   iXBRL 10-Q 823369
2 EXHIBIT 31.1 ex_664101.htm EX-31.1 9336
3 EXHIBIT 31.2 ex_664102.htm EX-31.2 9416
4 EXHIBIT 32.1 ex_664103.htm EX-32.1 7145
  Complete submission text file 0001437749-24-015699.txt   4182710

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arch-20240331.xsd EX-101.SCH 45648
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20240331_def.xml EX-101.DEF 303987
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20240331_lab.xml EX-101.LAB 241582
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20240331_pre.xml EX-101.PRE 325965
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arch-20240331_cal.xml EX-101.CAL 25005
59 EXTRACTED XBRL INSTANCE DOCUMENT arch20240331_10q_htm.xml XML 458230
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 24931268
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)